Artificial pancreas systems use sensors to measure blood glucose and pump operating parameters, but their control algorithms have few independent sensing parameters.
SURE+ is a disposable pump built on an elastomeric pump framework with a Fluonic flow sensor and regulator. It measures and controls infusion rates and communicates this information.
Fluonic's patented flow and material sensing technologies can be used for a number of applications ranging from drug infusion to urine monitoring as well as for use in an artificial pancreas to measure insulin.
Urine output is measured manually every half hour to two hours to help medical staff identify possible kidney damage, while most other physiological parameters are measured automatically and logged continuously.
Amir Genosar is founder and chief technology officer, with experience as a mechanical engineer, inventor, entrepreneur, and CEO in drug delivery devices. For 15 years, Genosar helped medical device and pharmaceutical companies develop drug delivery devices.
Fluonic was founded by Amir Genosar, who co-invented an infusion pump now being commercialized by SteadyMed. The company licensed two US patents for technology developed by Sandia National Laboratories.
